Here’s a story from The Nursing Site.com… In July of 2008, the Federal Drug Administration (FDA) began notifying the manufacturers of fluroquinlolone antimicrobial medications that they need to add a Boxed Warning about possible tendonitis and tendon ruptures to the product labels on these medications. The FDA also asks that patient education materials be distributed when the medication is dispensed. Tendon ruptures from these medications date back at least as far as 1997. From November 1997 to March 2007, the FDA has received reports of 336 cases of tendon ruptures in patients taking these medications. Fluroquinlolone is a broad spectrum antimicrobial medication used to treat bacterial infections in adults such…